Cite
APA Citation
Olshansky, B., Bhatt, D., Miller, M., Steg, P. G., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle Jr, R. T., Juliano, R. A., Jiao, L., Kowey, P., Reiffel, J. A., Tardif, J., Ballantyne, C. M., Chung, M. K., & , (n.d.). cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial). European heart journal, 42, . http://access.bl.uk/ark:/81055/vdc_100144497575.0x000036